__timestamp | Dr. Reddy's Laboratories Limited | Lantheus Holdings, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 12402000000 | 13673000 |
Thursday, January 1, 2015 | 17449000000 | 14358000 |
Friday, January 1, 2016 | 17834000000 | 12203000 |
Sunday, January 1, 2017 | 19551000000 | 18125000 |
Monday, January 1, 2018 | 18265000000 | 17071000 |
Tuesday, January 1, 2019 | 15607000000 | 20018000 |
Wednesday, January 1, 2020 | 15410000000 | 32788000 |
Friday, January 1, 2021 | 16541000000 | 44966000 |
Saturday, January 1, 2022 | 17482000000 | 311681000 |
Sunday, January 1, 2023 | 19381000000 | 77707000 |
Monday, January 1, 2024 | 22873000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, research and development (R&D) investment is a critical driver of innovation and growth. Over the past decade, Dr. Reddy's Laboratories Limited has consistently outpaced Lantheus Holdings, Inc. in R&D spending. From 2014 to 2023, Dr. Reddy's Laboratories increased its R&D investment by approximately 85%, peaking in 2024 with a notable 30% rise from the previous year. In contrast, Lantheus Holdings, while showing a significant spike in 2022, has generally maintained a more modest R&D budget, reflecting its strategic focus on niche markets. This disparity highlights the differing strategic priorities of these companies, with Dr. Reddy's Laboratories emphasizing broad-spectrum innovation, while Lantheus Holdings targets specialized advancements. As we look to the future, these investment trends may shape the competitive dynamics and market positioning of these pharmaceutical giants.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.